Latest Breaking News On - Early phase drug development - Page 1 : comparemela.com

Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO

/PRNewswire/ Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research being.

United statesNicole berryVivek subbiahShakti ramkissoonPratheesh sathyanPhase drug developmentPrnewswire illumina incSarah cannon research instituteAmerican society of clinical oncologyAmerican societyClinical oncologyAnnual meetingEarly phase drug development

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Palo altoUnited statesTotyana simienVivek subbiahRaquel izumiGabriela jairalaAhmed hamdySecurities exchangePhase drug developmentVincerx pharma incGlobenewswire incEuropean hematology association annual meetingAmerican association for cancer researchSarah cannon research instituteExchange commissionEuropean hematology association

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPalo altoGabriela jairalaTotyana simienAhmed hamdyVivek subbiahRaquel izumiExchange commissionSecurities exchangeEuropean hematology associationVincerx pharma incAmerican association for cancer researchPharma presents positive preliminary phasePipeline progressAmerican associationCancer research

Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline

VIP236 demonstrated positive signs of clinical activity, including tumor reduction, and an improved safety profile in heavily pretreated patients with metastatic solid tumors

Palo altoUnited statesTotyana simienGabriela jairalaAhmed hamdyVivek subbiahRaquel izumiExchange commissionSecurities exchangeVincerx pharma incEuropean hematology associationAmerican association for cancer researchAmerican associationCancer researchAnnual meetingChief executive officer

Vincerx Pharma (VINC) Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress

Vincerx Pharma (VINC) Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRaquel izumiVivek subbiahAhmed hamdyEuropean hematology associationVincerx pharma incAmerican association for cancer researchVincerx pharmaAmerican associationCancer researchAnnual meetingChief executive officerHematology associationChief operating officerEarly phase drug developmentSarah cannon research institute